Trial Profile
The Analgesic Efficacy of delta-9-THC (Namisol) in Patients With Persistent Postsurgical Abdominal Pain; a Randomized, Double Blinded, Placebo-controlled, Experiment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Abdominal pain; Postoperative pain
- Focus Therapeutic Use
- 27 Oct 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 19 Nov 2012 The first patient has been dosed according to an Echo Pharmaceuticals media release. The trial is expected to be completed in the fourth quarter of 2013.
- 15 Nov 2012 Planned End Date changed from 1 Jan 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.